Publications of Yvonne Genzel
All genres
Journal Article (105)
21.
Journal Article
105, pp. 7251 - 7264 (2021)
Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied Microbiology and Biotechnology 22.
Journal Article
105 (1), pp. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology 23.
Journal Article
9 (7), 706 (2021)
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor. Vaccines 24.
Journal Article
105 (5), pp. 1861 - 1874 (2021)
Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins. Applied Microbiology and Biotechnology 25.
Journal Article
95 (24), e01174-21 (2021)
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. Journal of Virology 26.
Journal Article
288 (16), pp. 4869 - 4891 (2021)
Comprehensive N‐glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells. The FEBS Journal 27.
Journal Article
11 (1), 5147 (2021)
Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins. Scientific Reports 28.
Journal Article
105 (4), pp. 1421 - 1434 (2021)
High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells. Applied Microbiology and Biotechnology 29.
Journal Article
8, 672 (2020)
Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode. Frontiers in Bioengineering and Biotechnology 30.
Journal Article
104 (11), pp. 4877 - 4888 (2020)
Performance of an Acoustic Settler Versus a Hollow Fiber-Based ATF Technology for Influenza Virus Production in Perfusion. Applied Microbiology and Biotechnology 31.
Journal Article
117 (10), pp. 3040 - 3052 (2020)
Virus harvesting in perfusion culture: Choosing the right typeof hollow fiber membrane. Biotechnology and Bioengineering 32.
Journal Article
21 (17), 6111 (2020)
Cell Bank Origin of MDCK Parental Cells Shapes Adaptation to Serum-Free Suspension Culture and Canine Adenoviral Vector Production. International Journal of Molecular Sciences 33.
Journal Article
117 (5), pp. 1533 - 1553 (2020)
A dynamic model linking cell growth to intracellular metabolism and extracellular by‐product accumulation. Biotechnology and Bioengineering 34.
Journal Article
37 (47), pp. 7003 - 7010 (2019)
Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production. Vaccine 35.
Journal Article
37 (47), pp. 7011 - 7018 (2019)
Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems. Vaccine 36.
Journal Article
Use of sulfated cellulose membrane adsorbers for chromatographic purification of cell cultured-derived influenza A and B viruses. Separation and Purification Technology (226), pp. 350 - 358 (2019)
37.
Journal Article
37 (47), pp. 7019 - 7028 (2019)
Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1. Vaccine 38.
Journal Article
7, 275 (2019)
Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling. Frontiers in Bioengineering and Biotechnology 39.
Journal Article
14 (11), e0224317 (2019)
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”. PLoS One 40.
Journal Article
103 (7), pp. 3025 - 3035 (2019)
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system. Applied Microbiology and Biotechnology